Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Bacon et al v. Stiefel Laboratories, Inc. et al
Case Number:
1:09-cv-21871
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Akerman LLP
- Buchanan Ingersoll
- Clarke Silverglate
- Greenberg Traurig
- Greenspoon Marder
- Lubell Rosen
- Podhurst Orseck
- Rafferty Kobert
- Walton Lantaff
Companies
Sectors & Industries:
-
June 17, 2016
Greenspoon's Cost Bid In $1.8M Stiefel ERISA Suit Too High
A Florida federal judge sorting out Greenspoon Marder's fight for litigation costs from a nearly $1.8 million securities fraud case against a GlaxoSmithKline unit ruled Thursday that the firm’s bid for roughly $560,000 “grossly exceeds” the “reasonable and necessary” amount it is entitled to after a pretrial withdrawal.
-
May 17, 2012
Stiefel Must Pay Sales Rep $1.5M In ERISA, Fraud Suit
A Florida federal jury on Wednesday ordered Stiefel Laboratories Inc. to pay $1.5 million for tricking a former sales representative into selling Stiefel shares back to the company at artificially low prices shortly before it was bought by GlaxoSmithKline PLC.
-
January 18, 2012
Stiefel Can't Shake ERISA, Fraud Claims Over GSK Buy
A Florida federal judge on Tuesday shot down Stiefel Laboratories Inc.'s bid to toss a lawsuit alleging it tricked a former sales representative into selling Stiefel shares back to the company at artificially low prices before it was bought by GlaxoSmithKline PLC.
-
November 01, 2011
Stiefel Will Get Split Trial For ERISA, Stock Fraud Claims
Stiefel Laboratories Inc. won its bid for a bifurcated trial Tuesday in an Employee Retirement Income Security Act and securities fraud case claiming that workers were duped into selling Stiefel shares back to the company at artificially low prices before its acquisition by GlaxoSmithKline PLC.
-
July 22, 2011
Stiefel ERISA Plaintiffs Lose Class Cert. Bid
A Florida federal judge refused Thursday to certify a class action accusing Stiefel Laboratories Inc. of significantly undervaluing its stock when it persuaded employees to resell their shares to the company on the eve of its acquisition by GlaxoSmithKline PLC.